151 related articles for article (PubMed ID: 34597373)
1. CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials.
Ganzel C; Lee JW; Fernandez HF; Paietta EM; Luger SM; Lazarus HM; Cripe LD; Douer D; Wiernik PH; Rowe JM; Tallman MS; Litzow MR
Blood Adv; 2021 Nov; 5(22):4560-4568. PubMed ID: 34597373
[TBL] [Abstract][Full Text] [Related]
2. Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008.
Ganzel C; Manola J; Douer D; Rowe JM; Fernandez HF; Paietta EM; Litzow MR; Lee JW; Luger SM; Lazarus HM; Cripe LD; Wiernik PH; Tallman MS
J Clin Oncol; 2016 Oct; 34(29):3544-3553. PubMed ID: 27573652
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system involvement in patients with acute myeloid leukemia.
Yaşar HA; Çınar OE; Köylü NY; Barışta İ; Göker H; Büyükaşık Y
Turk J Med Sci; 2021 Oct; 51(5):2351-2356. PubMed ID: 33932973
[TBL] [Abstract][Full Text] [Related]
4. Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome.
Del Principe MI; Buccisano F; Soddu S; Maurillo L; Cefalo M; Piciocchi A; Consalvo MI; Paterno G; Sarlo C; De Bellis E; Zizzari A; De Angelis G; Fraboni D; Divona M; Voso MT; Sconocchia G; Del Poeta G; Lo-Coco F; Arcese W; Amadori S; Venditti A
Semin Hematol; 2018 Oct; 55(4):209-214. PubMed ID: 30502849
[TBL] [Abstract][Full Text] [Related]
5. Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.
Rozovski U; Ohanian M; Ravandi F; Garcia-Manero G; Faderl S; Pierce S; Cortes J; Estrov Z
Leuk Lymphoma; 2015 May; 56(5):1392-7. PubMed ID: 25110819
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study.
Renaud J; Goemans BF; Locatelli F; Pigazzi M; Redmond S; Kuehni CE; Destaillats A; Alonzo TA; Gerbing RB; Gamis A; Aplenc R; Renella R; Cooper T; Ceppi F
Pediatr Blood Cancer; 2024 Jul; 71(7):e31006. PubMed ID: 38616361
[TBL] [Abstract][Full Text] [Related]
7. Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia.
Virijevic M; Kraguljac-Kurtovic N; Mitrovic M; Jakovic L; Bukumuric Z; Pantic N; Sabljic N; Pravdic Z; Cvetkovic M; Knezevic V; Dragovic-Ivancevic T; Djunić I; Rajic J; Milosevic V; Todorovic-Balint M; Vidovic A; Suvajdzic-Vukovic N
Hematol Oncol; 2024 Mar; 42(2):e3253. PubMed ID: 38536200
[TBL] [Abstract][Full Text] [Related]
8. Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1.
Bourlon C; Lipton JH; Deotare U; Gupta V; Kim DD; Kuruvilla J; Viswabandya A; Thyagu S; Messner HA; Michelis FV
Eur J Haematol; 2017 Sep; 99(3):234-239. PubMed ID: 28556258
[TBL] [Abstract][Full Text] [Related]
9. Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.
Ikegawa S; Doki N; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Yamamoto K; Hino Y; Shingai N; Senoo Y; Watanabe D; Hagino T; Yoshioka K; Watakabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Pathol Oncol Res; 2017 Apr; 23(2):433-437. PubMed ID: 28004352
[TBL] [Abstract][Full Text] [Related]
10. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
[TBL] [Abstract][Full Text] [Related]
11. Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
Felix A; Leblanc T; Petit A; Nelkem B; Bertrand Y; Gandemer V; Sirvent A; Paillard C; Schmitt C; Rohrlich PS; Fenneteau O; Ragu C; Michel G; Auvrignon A; Baruchel A; Leverger G
J Pediatr Hematol Oncol; 2018 Jan; 40(1):43-47. PubMed ID: 29189507
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement.
Goulart H; Sastow D; Moshier E; Martin L; Mascarenhas J; Tremblay D
Leuk Res; 2024 Feb; 137():107452. PubMed ID: 38335816
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group.
Johnston DL; Alonzo TA; Gerbing RB; Aplenc R; Woods WG; Meshinchi S; Gamis AS
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28453910
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
Duan WB; Gong LZ; Jia JS; Zhu HH; Zhao XS; Jiang Q; Zhao T; Wang J; Qin YZ; Huang XJ; Jiang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):990-995. PubMed ID: 29263470
[TBL] [Abstract][Full Text] [Related]
15. Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group.
Rowe JM; Kim HT; Cassileth PA; Lazarus HM; Litzow MR; Wiernik PH; Tallman MS
Cancer; 2010 Nov; 116(21):5012-21. PubMed ID: 20629023
[TBL] [Abstract][Full Text] [Related]
16. Proportion and Pattern of Central Nervous System Involvement in Acute Leukemia on Diagnosis.
Yeasmin S; Rashid MH; Debnath MR; Rashid MM
Mymensingh Med J; 2022 Jan; 31(1):55-60. PubMed ID: 34999680
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience.
Filì C; Candoni A; Zannier ME; Olivieri J; Imbergamo S; Caizzi M; Nadali G; Di Bona E; Ermacora A; Gottardi M; Facchinelli D; Ciancia R; Lazzarotto D; Dubbini MV; Festini G; Gherlinzoni F; Michieli MG; Semenzato G; Fanin R
Leuk Res; 2019 Jan; 76():33-38. PubMed ID: 30529681
[TBL] [Abstract][Full Text] [Related]
18. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
Li X; Xu S; Tan Y; Chen J
Cochrane Database Syst Rev; 2015 Jun; (6):CD010432. PubMed ID: 26037486
[TBL] [Abstract][Full Text] [Related]
19. Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET.
Cribe AS; Steenhof M; Marcher CW; Petersen H; Frederiksen H; Friis LS
Eur J Haematol; 2013 Apr; 90(4):273-8. PubMed ID: 23470093
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
